The First Greater Bay Area Biotechnology and Translational Medicine International Collaboration in the United States · China · Guangdong - Hong Kong - Macau Greater Bay Area

The Hong Kong Polytechnic University (PolyU) has long endeavoured to the development of translational medicine and biotechnology research. Together with alliance partners from the Guangdong - Hong Kong - Macau Greater Bay Area including Sun Yat-sen University, Shenzhen University, Macau University of Science and Technology, PolyU will initiate a collaboration with The State University of New York at Buffalo (SUNY Buffalo) and Roswell Park Comprehensive Cancer Center. The MoU Signing Ceremony, which takes place on 2 February 2018 at PolyU and signed by these six universities/institutions, signifies the first biotechnology and translational medicine research platform for collaboration among the United States and the Guangdong – Hong Kong – Macau Greater Bay Area.

The collaboration will pull together expertise from the collaborating parties and their networks, enabling the advancement of technology development. Leveraging the opportunities provided by the Greater Bay Area, the collaboration would foster more applied research in biotechnology, and bring innovations in the areas of cancer, genomics, translational medicine, and other related areas in biotechnology. The partners’ understanding of the regulatory procedures in their own countries will help expedite the translation of innovate technologies to applications and benefit the global community.

During the visit, ITDO arranged a roundtable meeting between the delegates from collaborating parties and Ir Professor Ping-kong Alexander Wai, Vice President of PolyU to highlight the latest progress of PolyU’s technology development and our effort in biotechnology and translational medicine research. The delegates were arranged to visit PolyU’s Shenzhen Research Institute - The State Key Laboratory of Chinese Medicine and Molecular Pharmacology (Incubation) to recognize our modernized Chinese medicine research and Shenzhen University General Hospital which is equipped with international medical facilities.

PolyU has already initiated collaborations with different partners in various areas such as “big health” with Sun Yat-sen University, joint research on drug delivery with the Shenzhen University, joint genomics research with Macau University of Science and Technology, and bioinformatics research with University at Buffalo. University at Buffalo is home to one of the top pharmacy schools in the US, and Roswell Park’s consistent success in cancer research has earned it the National Cancer Institute’s designation of “comprehensive cancer center.” It is the only facility in Upstate New York to hold this honor. Riding on the strength of each partner from the Guangdong – Hong Kong – Macau Greater Bay Area, the collaborative platform is expected to generate immense impact towards the development of the Greater Bay Area into a biotechnology hub.

For the full media release, please click here.
To view the snapshots, please visit here.